Thailand Biosimilars Market (2024-2030) Outlook | Size, Revenue, Analysis, Forecast, Companies, Trends, Growth, Share, Industry & Value

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069944 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Thailand Biosimilars Market Synopsis

The biosimilars market in Thailand has experienced significant growth in recent years, driven by increasing demand for cost-effective and accessible biologic drugs. Biosimilars are highly similar versions of reference biologics, offering comparable therapeutic outcomes and safety profiles at a lower cost. These products play a crucial role in expanding patient access to advanced therapies and reducing healthcare expenditure. The Thailand government`s efforts to promote biosimilar adoption, coupled with the rising prevalence of chronic diseases, have contributed to the market`s expansion. Biosimilar manufacturers in Thailand are actively engaged in research, development, and partnerships to strengthen their market presence.

Market Drivers

The biosimilars market in Thailand has experienced significant growth in recent years, driven by increasing demand for cost-effective and accessible biologic drugs. Biosimilars are highly similar versions of reference biologics, offering comparable therapeutic outcomes and safety profiles at a lower cost. These products play a crucial role in expanding patient access to advanced therapies and reducing healthcare expenditure. The Thailand government`s efforts to promote biosimilar adoption, coupled with the rising prevalence of chronic diseases, have contributed to the market`s expansion. Biosimilar manufacturers in Thailand are actively engaged in research, development, and partnerships to strengthen their market presence.

Challenges of the Market

While the biosimilars market presents significant opportunities, it also faces several challenges. One major hurdle is the complexity and cost of biosimilar development and manufacturing. Biosimilars require extensive analytical, preclinical, and clinical studies to demonstrate similarity to the reference product, making the development process time-consuming and resource-intensive. Additionally, concerns related to immunogenicity and interchangeability with the reference biologics require thorough evaluation and communication to gain the confidence of healthcare providers and patients. Moreover, intellectual property and legal considerations may pose barriers for biosimilar manufacturers, especially when navigating patent disputes with originator companies.

Covid-19 Impact on the Market

The Covid-19 pandemic has had a mixed impact on the biosimilars market in Thailand. While the immediate focus was on managing the pandemic, the demand for biosimilars remained resilient due to their cost-effective nature and the need to continue essential treatments. However, disruptions in healthcare services and supply chains during the pandemic did affect biosimilar distribution and uptake to some extent. The pandemic also highlighted the importance of a secure and sustainable supply of essential medicines, emphasizing the need for a robust and diversified biosimilars market in Thailand.

Key Players of the Market

The biosimilars market in Thailand is supported by several key players, both local and multinational. Local companies such as BioNet-Asia Co., Ltd. and Siam Bioscience Co., Ltd. have been actively engaged in the development and manufacturing of biosimilars for the domestic and international markets. Additionally, multinational pharmaceutical companies like Pfizer Inc., Novartis AG, and Celltrion, Inc. have a significant presence in the Thailand biosimilars market, leveraging their global expertise and research capabilities. These key players engage in partnerships with healthcare institutions, government bodies, and international organizations to strengthen their biosimilars portfolio and enhance patient access to affordable and high-quality biologic therapies in Thailand.

Key Highlights of the Report:

  • Thailand Biosimilars Market Outlook
  • Market Size of Thailand Biosimilars Market, 2020
  • Forecast of Thailand Biosimilars Market, 2027
  • Historical Data and Forecast of Thailand Biosimilars Revenues & Volume for the Period 2023 - 2027
  • Thailand Biosimilars Market Trend Evolution
  • Thailand Biosimilars Market Drivers and Challenges
  • Thailand Biosimilars Price Trends
  • Thailand Biosimilars Porter's Five Forces
  • Thailand Biosimilars Industry Life Cycle
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Product for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Insulin for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Follitropin for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Calcitonin for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Glucagon for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Teriparatide for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Indication for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Oncology for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Manufacturing for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By Outsourced for the Period 2023 - 2027
  • Historical Data and Forecast of Thailand Biosimilars Market Revenues & Volume By In-house for the Period 2023 - 2027
  • Thailand Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • Thailand Biosimilars Top Companies Market Share
  • Thailand Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • Thailand Biosimilars Company Profiles
  • Thailand Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Thailand Biosimilars Market Overview

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Biosimilars Market Revenues & Volume, 2020 & 2027F

3.3 Thailand Biosimilars Market - Industry Life Cycle

3.4 Thailand Biosimilars Market - Porter's Five Forces

3.5 Thailand Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 Thailand Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F

3.7 Thailand Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F

4 Thailand Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Thailand Biosimilars Market Trends

6 Thailand Biosimilars Market, By Types

6.1 Thailand Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 Thailand Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 Thailand Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 Thailand Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 Thailand Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 Thailand Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 Thailand Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 Thailand Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 Thailand Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 Thailand Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 Thailand Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 Thailand Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 Thailand Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 Thailand Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 Thailand Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 Thailand Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 Thailand Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 Thailand Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 Thailand Biosimilars Market Import-Export Trade Statistics

7.1 Thailand Biosimilars Market Export to Major Countries

7.2 Thailand Biosimilars Market Imports from Major Countries

8 Thailand Biosimilars Market Key Performance Indicators

9 Thailand Biosimilars Market - Opportunity Assessment

9.1 Thailand Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 Thailand Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F

9.3 Thailand Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F

10 Thailand Biosimilars Market - Competitive Landscape

10.1 Thailand Biosimilars Market Revenue Share, By Companies, 2020

10.2 Thailand Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All